Lv6
1635 积分 2021-01-15 加入
Prevalence, clinical characteristics and outcomes of seizures in neurofibromatosis type 1: A systematic review and single arm meta-analysis
3天前
已完结
Neurofibromatosis Type 1 Patients With Epilepsy: A Comprehensive Analysis of Demographics, Comorbidities and Healthcare Outcomes
9天前
已完结
T2 Hyperintensities in Children with Neurofibromatosis Type 1
20天前
已完结
Vascular Abnormalities and Neurofibromatosis Type 1: A Paediatric Case Series
20天前
已完结
Lamotrigine for cognitive deficits associated with neurofibromatosis type 1: A phase II randomized placebo‐controlled trial
1个月前
已完结
Antiseizure effect of MEK inhibitor in a child with neurofibromatosis type 1—Developmental and epileptic encephalopathy and optic pathway glioma
1个月前
已完结
Treatment of Refractory Epilepsy With MEK Inhibitor in Patients With RASopathy
1个月前
已完结
Glial plasticity dysregulation contributes to learning impairments in the neurogenetic disorder NF1
2个月前
已完结
Consensus recommendations on management of selumetinib-associated adverse events in pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas
2个月前
已完结
Lymphocytes in autoimmune encephalitis: Pathogenesis and therapeutic target
2个月前
已完结
皖公网安备34019202002308
